United Kingdom

Back to map

Showing 11-20 of 36 grants

Title Institution Researcher Program Duration Total Award Amount
MQ Foundation — JDRF Partnership MQ Foundation Jey Balakrishnar Improving Lives 31-March-2023 to 30-March-2026 $137,637.50
My T1D Care Tool: Co-Creating a digital psychosocial measure for young people living with Type 1 Diabetes as part of routine healthcare management Queen's University Belfast Emma Berry Improving Lives 01-July-2023 to 30-June-2026 $109,958.00
Targeting alpha/beta hydrolase domain containing 11 (ABHD11) as a therapeutic target in type 1 diabetes Swansea University Nicholas Jones Cures 01-April-2026 to 31-March-2029 $621,914.00
Macrophages To Promote The Long-Term Function Of Islets Following Transplantation For Type 1 Diabetes. The University of Edinburgh Shareen Forbes Cures 01-March-2024 to 28-February-2027 $748,578.27
Unraveling the Mechanisms of HLA-DQ8 Graft Acceptance: Insights from the Largest Single Cohort of Islet Transplant Recipients in the Edmonton Program The University of Edinburgh Shareen Forbes Cures 01-October-2025 to 30-September-2027 $749,938.79
Progressing 4 antibody multiplex Lateral flow assay for Diabetes (Diabetes 4ward) University of Birmingham Alex Richter Cures 01-August-2024 to 31-July-2026 $705,592.01
Can dysregulated immunity to bacterial lipopolysaccharide aid in identifying those at risk of developing Type 1 diabetes? University of Birmingham James Pearson Cures 01-April-2026 to 31-March-2029 $667,691.00
Establishing the effectiveness, safety and acceptability of treatments to preserve beta cell function in people with type 1 diabetes (T1D) University of Birmingham Parth Narendran Cures 01-September-2024 to 31-August-2027 $279,997.78
Genetic risk modelling and implementation of EarLy Surveillance for Autoimmune Diabetes (ELSA) University of Birmingham Parth Narendran Cures 01-February-2026 to 31-January-2030 $653,050.94
Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study University of Birmingham Parth Narendran Cures 01-March-2022 to 31-August-2025 $585,569.82